Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.0%

4 terminated out of 80 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

11%

9 trials in Phase 3/4

Results Transparency

13%

5 of 39 completed with results

Key Signals

5 with results91% success

Data Visualizations

Phase Distribution

43Total
Not Applicable (26)
Early P 1 (1)
P 1 (7)
P 3 (3)
P 4 (6)

Trial Status

Completed39
Unknown23
Recruiting11
Terminated4
Active Not Recruiting2
Not Yet Recruiting1

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 39 completed trials

Clinical Trials (80)

Showing 20 of 20 trials
NCT03555981Not ApplicableTerminated

Early Kangaroo Mother Care in Gambian Hospitalised Unstable Neonates

NCT05993442Not ApplicableRecruitingPrimary

Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in NICU.

NCT02992951Not ApplicableCompletedPrimary

DACC in the REduction of Surgical Site INfection

NCT05960006Completed

A Study to Determine Pharmacokinetic Changes of Ceftriaxone in Patients With Liver Cirrhosis

NCT04894500CompletedPrimary

ICIS in Burn Patients Compared to Other Inflammatory Markers

NCT03163628Not ApplicableCompletedPrimary

biomArkers to differeNtiate bacTerial From vIral iNfEctions

NCT06548841Completed

Development and Validation of (Bio)Sensors for the Identification of Pathogens

NCT06093269Phase 4Active Not Recruiting

Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)

NCT05846399Phase 4Recruiting

CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)

NCT06178822Recruiting

Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

NCT05150015Not ApplicableCompletedPrimary

ElastoMeric Infusion Pumps for Hospital AntibioTICs

NCT04282785Completed

Point-of-care Monitoring of Antibiotic Concentration in Blood With UV-VIS Absorption Spectroscopy

NCT06379061CompletedPrimary

Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts

NCT01904188Recruiting

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

NCT05950984CompletedPrimary

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

NCT05914779Not ApplicableRecruitingPrimary

Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)

NCT04484740Phase 1Completed

Penetration of the Innovative Antibiotic Gepotidacin Into Prostate and Tonsillar Tissue

NCT02754765Phase 3Completed

Evaluating Newly Approved Drugs for Multidrug-resistant TB

NCT05082909Phase 1CompletedPrimary

Addition of Probenecid to Penicillin-V Therapy

NCT04070469Phase 4CompletedPrimary

Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment (MAX-AMOX)

Scroll to load more

Research Network

Activity Timeline